Faculty Information - INUI Masashi

Published papers

Academic conference presentation

Social activities

Education

Academic & professional experience

（Last updated : 2024-04-12 11:41:47）

INUI Masashi
Department School of Medicine(Yachiyo Medical Center), School of Medicine

Position Professor

■ Published papers

1.	Original article	Clinicopathological analyses of chronic renal allograft arteriopathy after kidney transplantation. 2023/11
2.	Original article	A case of kidney transplantation for complete C4 deficiency with recurrent IgM-monoclonal gammopathy of renal significance (MGRS) associated nephropathy. 2023/09
3.	Original article	Predictors of long-term urinary incontinence after robot-assisted laparoscopic prostatectomy. 2023/08/21
4.	Original article	Comparison of three prognostic and predictive scores in 10 patients with COVID-19 pneumonia caused by nosocomial infection. 2023/07
5.	Original article	Case report: suspected hyperacute rejection during living kidney transplantation. 2023/05/01
6.	Case report	Allogeneic kidney transplantation after COVID-19: A case report. 2022/07
7.	Case report	Case report of COVID-19 infection after kidney transplantation treated with casirivimab-imdevimab and mycophenolate mofetil changed to everolimus. 2022/07
8.	Case report	Suspected pneumonia caused by coronavirus disease 2019 after kidney transplantation: A case report. 2022/07
9.	Original article	Japanese single-center experience of kidney transplant: Experience in a Japanese private hospital. 2022/03
10.	Case report	Two laparotomy surgeries to achieve hemostasis after kidney transplantation in a patient with frailty: a case report. 2022/01
11.	Case report	Fluorescence in situ hybridization for the origin of de novo renal cell carcinoma in a kidney allograft: A case report. 2021/10
12.	Case report	Venous Thromboembolism After the repair of Abdominal Incisional Hernia with a Pedicled Anterolateral Thigh Flap 2020/04/01
13.	Original article	Once-daily vs twice-daily tacrolimus for de novo living kidney transplantation patients including ABO/HLA compatible and incompatible:A randomized trial. 2018/12
14.	Original article	Follow-up Survey of Donor Candidates for Living Related Kidney Transplantation With Prostate Cancer. 2018/10
15.	Original article	Assessment of 4 cases of kidney transplantation from hepatitis C virus antibody-positive and RNA-negative donors to antibody-negative recipients. 2016/09
16.	Original article	Interstitial fibrosis is the critical determinant of impaired renal function in transplant glomerulopathy. 2016/07
17.	Case report	Successful kidney transplantation after stepwise desensitization using rituximab and bortezomib in a highly HLA-sensitized and ABO incompatible high titer patient. 2016/07
18.	Original article	Robot-assisted radical prostatectomy for localized prostate cancer in asian renal transplant recipients. 2016/04
19.	Original article	ABO-Incompatible living kidney transplants: Evolution of outcomes and immunosuppressive management. 2016/03
20.	Original article	Reliability of tacrolimus determination using Electro-Chemiluminesence Immunoas-say(ECLIA). 2016/03
21.	Original article	Retroperitoneoscopic donor nephrectomy with multiple renal arteries does not affect graft survival and ureteral complications. 2014/12
22.	Review article	Transplantation and the Most Advanced Medical Treatment Transplantation(5) Current Situation and Issues for Kidney 2014/08
23.	Original article	Desensitization for prevention of chronic antibody-mediated rejection after kidney transplantation 2013/11
24.	Original article	Impact of right-sided nephrectomy on long-term outcomes in retroperitoneoscopic live donor nephrectomy at single center 2013/10
25.	Original article	Kidney Transplantation at Tokyo Women's Medical University 2012
26.	Original article	Kidney Transplantation at Tokyo Women's Medical University 2011
Display 5 items
Display all(26)

■ Academic conference presentation

1.	Safety and efficacy of hypoxia-inducible factor prolyl hydroxylase inhibitor in kidney transplant patients with post-transplant anemia. 2023/06/05
2.	Outcomes of kidney transplantation recipients with Covid-19 infection : 282 Cases of a Single-Center experience. 2023/06/03
3.	Analysis of predictors of urinary incontinence after robot-assisted radical prostatectomy. 2023/04/22
4.	Robotic-assisted radical cystectomy (RARC): Initial experience at Tokyo Women's Medical University Yachiyo Medical Center. 2023/04/20
5.	A case of living kidney transplantation suspected of hyper-acute rejection during kidney transplant surgery. 2022/11/26
6.	Clinicopathological analyses of chronic vascular rejection after kidney transplantation. 2022/11/26
7.	Influence of HLA epitope mismatch on the kidney allograft after transplantation. 2022/11/26
8.	Outcomes of kidney transplantation recipients with SARS-CoV-2 infection: A single-center experience. 2022/11/26
9.	Short-term outcome of ABO incompatible kidney transplantation in elderly end-stage kidney disease patients. 2022/11/26
10.	Antibody responses to BNT162b2 booster in kidney transplant recipients vacci‐nated twice. 2022/10/24
11.	Impact of rituximab induction therapy on donor-specific anti-HLA antibodies in abo-compatible kidney transplant recipients. 2021/06/04
12.	Relationship between tacrolimus blood levels and covid-19 pandemic in kidney transplant recipients. 2021/06/04
13.	Initial experience of robot-assisted laparoscopic cystectomy. 2020/12/22
14.	Kidney transplantation for elderly patients and long term dialysis patients. 2020/12/22
15.	Outcomes of retroperitoneoscopic live donor nephrectomy (RPLDN): Experience of 1100 cases at a single center. 2018/06/04
16.	High prevalence of kidney transplant-associated thrombotic microangiopathy after ABO-incompatible kidney transplantation: Risk factors, rapid clinical diagnosis, and prompt successful treatment. 2018/06/03
17.	Once-daily versus twice-daily tacrolimus in living kidney transplantation: A Multicenter, parallel group, open-label, 5-year, randomized non-inferiority trial. 2017/05/02
18.	ABO-incompatible living kidney transplantation at multicenter Japanese case series: Evolution of outcomes and immunosuppressive management. 2016/10/29
19.	Is life-long prophylaxis the only way to prevent pneumocystis jiroveci pneumonia? 2016/10/29
20.	Comparison of the pharmacokinetics and pathology for low-dose once-daily and twice-daily tacrolimus following living kidney transplantation: Five-year results from a prospective trial. 2016/08/20
21.	Relationship between dialysis duration and prevalence of cardiovascular diseases in kidney transplantation recipients. 2016/08/20
22.	Glomerular capillary C4d staining without evidence of rejection is associated with worse graft function in ABO-incompatible Kidney Transplantation. 2016/06/13
23.	Pharmakokinetics of prolonged-release formulation of tacrolimus:Comparison of AUC0-24 and concentration at 10 time points. 2016/06/13
24.	Relationship between dialisys duration and prevalence of cardiovascular diseases in kidney transplantation recipients. 2016/06/13
25.	ABO-incompatible living kidney transplantation at multicenter Japanese case series: evolution of outcomes and immunosuppressive management. 2016/06/11
26.	Clinical outcome of elderly living kidney donors: A single-center study in Japan. 2016/06/11
27.	Preoperative prostate imaging reporting and data system score: An independent predictor of positive surgical margin after robot-assisted radical prostatectomy. 2016/05/08
28.	An Investigation of 13 Cases of Membranous Nephropathy of the Donor Origin Accidentally Detected by 0-h Renal Biopsy During Kidney Transplantation 2015/11/07
29.	Short-term outcomes of angioplasty in situ for renal artery aneurysm. 2015/05/18
30.	Interstitial fibrosis is the critical determinant of impaired renal function in transplant glomerulopathy. 2015/05/03
31.	Intimal arteritis associated with subsequent graft dysfunction in ABO-incompatible kidney transplantation. 2015/05/02
32.	Comparison of once-daily and twice-daily low-dose tacrolimus in living related kidney transplantation -prospective trial of once-daily vs. twice-daily tac -3 years second report. 2014/07/29
33.	Long-term (more than 20 years) outcome of ABO-incompatible living donor kidney transplantation: A single center experience. 2014/07/29
34.	Outcomes of pure retroperitoneoscopic live donor nephrectomy (RPLDN): single center experience of 764 cases. 2014/07/29
35.	Outcomes of retroperitoneoscopic live donor nephrectomy in patients with renal artery aneurysm. 2014/07/29
36.	Retroperitoneoscopic procurement of kidneys with multiple renal arteries does not affect graft survival and ureteral complications. 2014/07/29
37.	The correlation between results of ABO-incompatible living kidney transplantation and anti-ABO blood type antibody titers under our current immunosuppression including rituximab. 2014/07/29
38.	Assessment of long-term outcomes after kidney retransplantation. 2014/07/28
39.	Late-onset neutropenia (LON) After low-dose rituximab treatment in living related kidney transplantation.-Single-center study- 2014/07/28
40.	Low incidence of new onset diabetes mellitus after renal transplantation under low-dose tacrolimus-based immunosuppression: A single center experience. 2014/07/28
41.	Lower incidence rate of BK virus nephropathy, as detected by PCR screening, associated with lower doses of Tac/MMF at Tokyo Women's Medical University. 2014/07/28
42.	No necessity for prophylactic B-Cell-targeting treatment for postoperative high titers of anti-blood type antibodies after ABO-incompatible living related kidney transplantation. 2014/07/28
43.	Influences of the CD20 Ab rituximab on the renal transplant recipients and renal grafts 5 to 8 years after immunologically high-risk renal transplantation. 2014/07/27
44.	Long-term outcomes of living donor kidney transplantation in flow cytometry crossmatch-positive patients: A single-center experience. 2014/07/27
45.	Preliminary outcome of desensitization with super high dose IVIG, plasmapheresis, and rituximab for crossmatch-positive (highly sensitized) kidney transplant recipients. 2014/07/27
46.	Successful kidney transplantation after repeat desensitization using plasmapheresis, low-dose intravenous immunoglobulin, rituximab, and bortezomib in a highly HLA-sensitized and ABO incompatible patient: A case report. 2014/07/27
47.	A case of recurrent FSGS diagnosed as underlying disease following deceased donor kidney transplantation and a review of recurrent FSGS cases after transplantation at our institution 2013/09/04
48.	Evaluation of the association between histological findings of arteriosclerosis in zero-time biopsy and tacrolimus-induced nephrotoxicity 2013/09/04
49.	Incidence of Malignancy after Kidney Transplantation in the New Era of Immunosuppression 2013/05/21
50.	Development of De Novo Anti-HLA Antibodies after Treatment with/without Rituximab, a BCell-Depleting Treatment 2013/05/19
51.	Influence of Preoperative Anti-HLA Antibodies on Short-Term and Long-Term Graft Survival in Recipients With or Without Rituximab Treatment 2013/05/19
52.	MFI Detected by Luminex in Patients with Chronic Active Antibody Mediated Rejection 2012/10/20
53.	Outcomes of Retroperitoneoscopic Procurement of Kidneys with Multiple Renal Arteries 2012/10/20
54.	Clinical and Pathological Analysis of Transplant Glomerulopathy Cases 2012/07/19
55.	Clinicopathological Analysis of Acute Vascular Rejection Cases after Renal Transplantation 2012/07/19
56.	Quantitative Analysis of Humoral Immunity by Flow-Cytometric Crossmatch Combined with Molecules Equivalent Soluble Fluorochromosome (FCXM-MESF) for Classification of the Sensitization Status in Recipients of Renal Transplantation 2012/06/04
Display 5 items
Display all(56)

■ Social activities

2017/03

1st East Asia Transplant Expert Meeting Update of transplantation in each country Moderator

■ Education

1992/04～1996/03

〔Doctoral course〕, Graduate School, Division of Medicine, Kagawa Medical University, Completed, Medicine

■ Academic & professional experience

2020/12～

Tokyo Women's Medical University Yachiyo Medical Center Professor